ctDNA-driven Adaptive Proton Craniospinal Irradiation in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis After Resistance to Third-Generation TKIs in the Consolidation Phase

NCT07751536 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Leptomeningeal Metastasis From Lung Cancer

Interventions

RADIATION: proton craniospinal irradiation
DRUG: Intrathecal pemetrexed

Sponsor

Shuanghu Yuan